Seeking Alpha

GlaxoSmithKline's (GSK) $3B hit from the DoJ earlier this week is being billed as the...

GlaxoSmithKline's (GSK) $3B hit from the DoJ earlier this week is being billed as the “largest health care fraud settlement in U.S. history... unprecedented in both size and scope.” And nobody cares. Why? Because investors know that over the past decade, the two drugs behind the scandal, Paxil an Wellbutrin, together brought in more than seven times the amount of the settlement. Paxil brought in close to $14B, and Wellbutrin $8.5B. As is frequently the case in cases of corporate misdoings, crime and punishment aren't always relative.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs